200 related articles for article (PubMed ID: 37727209)
1. Cross-species evaluation of fibroblast activation protein alpha as potential imaging target for soft tissue sarcoma: a comparative immunohistochemical study in humans, dogs, and cats.
Beer P; Pauli C; Haberecker M; Grest P; Beebe E; Fuchs D; Markkanen E; Krudewig C; Nolff MC
Front Oncol; 2023; 13():1210004. PubMed ID: 37727209
[TBL] [Abstract][Full Text] [Related]
2. Comparative pathology of canine soft tissue sarcomas: possible models of human non-rhabdomyosarcoma soft tissue sarcomas.
Milovancev M; Hauck M; Keller C; Stranahan LW; Mansoor A; Malarkey DE
J Comp Pathol; 2015 Jan; 152(1):22-7. PubMed ID: 25435513
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical Evaluation of Candidate Biomarkers for Fluorescence-Guided Surgery of Myxofibrosarcoma Using an Objective Scoring Method.
Rijs Z; Belt E; Kalisvaart GM; Sier CFM; Kuppen PJK; Cleven AHG; Vahrmeijer AL; van de Sande MAJ; van Driel PBAA
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979961
[TBL] [Abstract][Full Text] [Related]
4. Candidate Biomarkers for Specific Intraoperative Near-Infrared Imaging of Soft Tissue Sarcomas: A Systematic Review.
Rijs Z; Shifai AN; Bosma SE; Kuppen PJK; Vahrmeijer AL; Keereweer S; Bovée JVMG; van de Sande MAJ; Sier CFM; van Driel PBAA
Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33535618
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast Activation Protein Expression in Sarcomas.
Crane JN; Graham DS; Mona CE; Nelson SD; Samiei A; Dawson DW; Dry SM; Masri MG; Crompton JG; Benz MR; Czernin J; Eilber FC; Graeber TG; Calais J; Federman NC
Sarcoma; 2023; 2023():2480493. PubMed ID: 37333052
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of using gene expression analysis to study canine soft tissue sarcomas.
Mahoney JA; Fisher JC; Snyder SA; Hauck ML
Mamm Genome; 2010 Dec; 21(11-12):577-82. PubMed ID: 21076837
[TBL] [Abstract][Full Text] [Related]
7. Canine Soft Tissue Sarcomas: Can Being a Dog's Best Friend Help a Child?
Séguin B
Front Oncol; 2017; 7():285. PubMed ID: 29218302
[TBL] [Abstract][Full Text] [Related]
8. The controversial histologic classification of canine subcutaneous whorling tumours: The path to perivascular wall tumours.
Avallone G; Stefanello D; Ferrari R; Roccabianca P
Vet Comp Oncol; 2020 Mar; 18(1):3-8. PubMed ID: 31778274
[TBL] [Abstract][Full Text] [Related]
9. Fibrosarcomas at presumed sites of injection in dogs: characteristics and comparison with non-vaccination site fibrosarcomas and feline post-vaccinal fibrosarcomas.
Vascellari M; Melchiotti E; Bozza MA; Mutinelli F
J Vet Med A Physiol Pathol Clin Med; 2003 Aug; 50(6):286-91. PubMed ID: 12887620
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical selection of biomarkers for tumor-targeted image-guided surgery of myxofibrosarcoma.
de Gooyer JM; Versleijen-Jonkers YMH; Hillebrandt-Roeffen MHS; Frielink C; Desar IME; de Wilt JHW; Flucke U; Rijpkema M
Sci Rep; 2020 Feb; 10(1):2915. PubMed ID: 32076024
[TBL] [Abstract][Full Text] [Related]
11. Unclassified sarcomas: a study to improve classification in a cohort of Golden Retriever dogs.
Boerkamp KM; Hellmén E; Willén H; Grinwis GC; Teske E; Rutteman GR
J Vet Diagn Invest; 2016 Nov; 28(6):623-631. PubMed ID: 27698172
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas.
Luong RH; Baer KE; Craft DM; Ettinger SN; Scase TJ; Bergman PJ
Vet Pathol; 2006 Sep; 43(5):622-31. PubMed ID: 16966439
[TBL] [Abstract][Full Text] [Related]
13. The effects of tumor location on diagnostic criteria for canine malignant peripheral nerve sheath tumors (MPNSTs) and the markers for distinction between canine MPNSTs and canine perivascular wall tumors.
Suzuki S; Uchida K; Nakayama H
Vet Pathol; 2014 Jul; 51(4):722-36. PubMed ID: 24009270
[TBL] [Abstract][Full Text] [Related]
14. Malignant fibrous histiocytomas in dogs and cats: an immunohistochemical study.
Thoolen RJ; Vos JH; van der Linde-Sipman JS; de Weger RA; van Unnik JA; Misdorp W; van Dijk JE
Res Vet Sci; 1992 Sep; 53(2):198-204. PubMed ID: 1332152
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of a canine soft tissue sarcoma patient-derived xenograft model.
Frazier JP; Beirne E; Ditzler SH; Tretyak I; Casalini JR; Thirstrup DJ; Knoblaugh S; Ward JG; Tripp CD; Klinghoffer RA
Vet Comp Oncol; 2017 Sep; 15(3):754-763. PubMed ID: 26991424
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profiling of canine fibrosarcoma and adjacent peritumoral tissue.
Beebe E; Pöschel A; Kunz L; Wolski W; Motamed Z; Meier D; Guscetti F; Nolff MC; Markkanen E
Neoplasia; 2023 Jan; 35():100858. PubMed ID: 36508875
[TBL] [Abstract][Full Text] [Related]
17. Incidence, distribution of histological subtypes and primary sites of soft tissue sarcoma in China.
Yang Z; Zheng R; Zhang S; Zeng H; Li H; Chen W
Cancer Biol Med; 2019 Aug; 16(3):565-574. PubMed ID: 31565485
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions.
Das S; Idate R; Lana SE; Regan DP; Duval DL
Sci Rep; 2023 Jun; 13(1):10422. PubMed ID: 37369741
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of targeting canine soft tissue sarcoma with MR-guided high-intensity focused ultrasound.
Seward MC; Daniel GB; Ruth JD; Dervisis N; Partanen A; Yarmolenko PS
Int J Hyperthermia; 2019 Jan; 35(1):205-215. PubMed ID: 30303425
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Expression of
Tsoi MF; Thaiwong T; Smedley RC; Noland E; Kiupel M
Front Vet Sci; 2021; 8():701457. PubMed ID: 34422947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
